Nifty

:

24287.65

Sensex

:

77728.16

-78.35 (-0.32%)
-281.09 (-0.36%)

Login

Nifty
Sensex

:
:

24287.65
77728.16

-78.35 (-0.32%)
-281.09 (-0.36%)

Oxygenta Pharmaceutical Ltd.

Pharmaceuticals & Drugs

Rating :

51/99

BSE: 524636 | NSE: Not Listed

Watchlist

NSE BSE

67.43

17-Aug-2026

Open
High
Low
Previous Close

66.69
69.5
66.4
65.38

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11519
779387
69.5
0

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

249.38
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

356.80
N/A
-5.57

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

30.07
13.30
41.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.18
-
9.56

PAT CAGR (%)

10 Years
5 Years
3 Years

11.70
95.83
71.55

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-5.91
-6.01
-8.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-23.31
-24.04
-27.87

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 37.00 15.13 144.55% 49.61 49.47 0.28% 33.93 33.69 0.71% 14.25 14.76 -3.46%
Expenses 36.45 21.96 65.98% 49.50 51.42 -3.73% 38.01 37.56 1.20% 18.88 16.18 16.69%
EBITDA 0.55 -6.83 - 0.11 -1.95 - -4.08 -3.87 - -4.63 -1.42 -
EBIDTM 1.48% -45.13% 0.23% -3.95% -12.01% -11.48% -32.51% -9.64%
Other Income 0.02 0.17 -88.24% 0.17 0.05 240.00% 0.00 0.00 0 0.00 0.00 0
Interest 2.46 0.63 290.48% 1.81 2.13 -15.02% 1.39 0.39 256.41% 0.95 0.69 37.68%
Depreciation 0.62 0.85 -27.06% -0.24 -0.23 - 0.86 0.71 21.13% 0.86 0.66 30.30%
PBT -2.51 -8.15 - -1.28 -3.80 - -6.33 -4.96 - -6.44 -2.77 -
Tax -0.40 -2.04 - 0.42 -1.65 - -1.48 -1.03 - -1.51 0.08 -
PAT -2.10 -6.11 - -1.70 -2.15 - -4.84 -3.93 - -4.93 -2.86 -
PATM -5.68% -40.34% -3.43% -4.35% -14.27% -11.66% -34.61% -19.35%
EPS -0.57 -1.65 - -0.46 -0.58 - -1.31 -1.06 - -1.33 -0.77 -

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 134.79 112.98 109.30 39.64 30.99 60.52 52.03 13.72 20.51 12.87 8.15 Net Sales Growth 19.23% 3.37% 175.73% 27.91% -48.79% 16.32% 279.23% -33.11% 59.36% 57.91% Cost Of Goods Sold 117.43 102.14 96.47 33.53 24.01 47.22 36.63 15.58 16.08 9.93 5.64 Gross Profit 17.36 10.85 12.83 6.11 6.98 13.30 15.40 -1.87 4.43 2.94 2.52 GP Margin 12.88% 9.60% 11.74% 15.41% 22.52% 21.98% 29.60% -13.63% 21.60% 22.84% 30.92% Total Expenditure 142.84 128.29 119.11 49.34 38.10 59.05 48.18 21.58 22.55 16.87 13.00 Power & Fuel Cost - 6.14 6.35 4.15 4.16 3.04 2.79 1.00 0.89 1.12 1.08 % Of Sales - 5.43% 5.81% 10.47% 13.42% 5.02% 5.36% 7.29% 4.34% 8.70% 13.25% Employee Cost - 7.64 6.85 5.99 5.74 0.92 4.08 2.50 2.71 2.90 2.86 % Of Sales - 6.76% 6.27% 15.11% 18.52% 1.52% 7.84% 18.22% 13.21% 22.53% 35.09% Manufacturing Exp. - 9.10 5.85 3.28 2.43 5.97 2.88 1.32 1.38 1.45 1.67 % Of Sales - 8.05% 5.35% 8.27% 7.84% 9.86% 5.54% 9.62% 6.73% 11.27% 20.49% General & Admin Exp. - 2.34 2.18 2.24 1.72 1.88 1.78 1.12 1.33 1.36 1.59 % Of Sales - 2.07% 1.99% 5.65% 5.55% 3.11% 3.42% 8.16% 6.48% 10.57% 19.51% Selling & Distn. Exp. - 0.29 0.42 0.11 0.04 0.00 0.01 0.05 0.10 0.04 0.11 % Of Sales - 0.26% 0.38% 0.28% 0.13% 0% 0.02% 0.36% 0.49% 0.31% 1.35% Miscellaneous Exp. - 0.64 0.99 0.02 0.01 0.01 0.01 0.01 0.06 0.06 0.11 % Of Sales - 0.57% 0.91% 0.05% 0.03% 0.02% 0.02% 0.07% 0.29% 0.47% 0.61% EBITDA -8.05 -15.31 -9.81 -9.70 -7.11 1.47 3.85 -7.86 -2.04 -4.00 -4.85 EBITDA Margin -5.97% -13.55% -8.98% -24.47% -22.94% 2.43% 7.40% -57.29% -9.95% -31.08% -59.51% Other Income 0.19 0.29 1.31 0.04 0.02 0.00 0.09 0.03 0.31 1.36 0.62 Interest 6.61 4.83 2.23 1.59 1.49 0.92 1.78 1.09 0.75 0.90 0.60 Depreciation 2.10 2.32 3.61 2.66 2.05 1.59 1.20 1.00 1.02 0.94 0.90 PBT -16.56 -22.18 -14.35 -13.91 -10.64 -1.04 0.95 -9.93 -3.49 -4.48 -5.72 Tax -2.97 -4.61 -4.05 -10.39 0.20 0.12 0.21 -0.15 -0.24 0.05 0.09 Tax Rate 17.93% 20.78% 28.22% 74.91% -1.76% -24.49% 6.69% 2.53% 6.88% -1.12% -1.57% PAT -13.57 -17.57 -10.30 -3.48 -11.57 -0.61 2.93 -5.79 -3.25 -4.53 -5.81 PAT before Minority Interest -13.57 -17.57 -10.30 -3.48 -11.57 -0.61 2.93 -5.79 -3.25 -4.53 -5.81 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -10.07% -15.55% -9.42% -8.78% -37.33% -1.01% 5.63% -42.20% -15.85% -35.20% -71.29% PAT Growth 0.00% - - - - - - - - - EPS -3.67 -4.75 -2.78 -0.94 -3.13 -0.16 0.79 -1.56 -0.88 -1.22 -1.57

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds -42.69 -25.64 -20.12 -46.20 -34.63 -38.02 -40.95 -35.16 -31.91 -27.38 Share Capital 36.98 36.98 33.48 14.20 14.20 10.20 10.20 10.20 10.20 10.20 Total Reserves -79.67 -62.62 -54.17 -60.40 -48.83 -48.22 -51.15 -45.36 -42.11 -37.58 Non-Current Liabilities 58.86 9.61 40.89 67.57 57.74 54.39 43.72 39.59 30.73 30.68 Secured Loans 23.17 2.63 3.40 37.01 32.77 0.00 0.50 0.50 1.76 1.93 Unsecured Loans 52.11 18.89 45.60 25.24 18.27 45.04 24.94 20.37 16.26 16.56 Long Term Provisions 0.98 1.08 0.62 0.59 2.50 2.66 0.00 0.00 0.00 0.00 Current Liabilities 86.10 85.85 33.70 32.90 8.07 17.50 15.85 16.73 18.14 15.77 Trade Payables 48.77 29.79 22.89 23.78 6.46 13.79 8.10 8.95 10.76 9.26 Other Current Liabilities 5.64 15.88 3.27 3.58 0.41 0.77 6.27 6.31 6.15 5.85 Short Term Borrowings 31.43 39.94 7.46 4.97 1.09 2.85 0.50 0.49 0.24 0.00 Short Term Provisions 0.26 0.23 0.07 0.57 0.12 0.09 0.97 0.98 1.00 0.66 Total Liabilities 102.27 69.82 54.47 54.27 31.18 33.87 18.62 21.16 16.96 19.07 Net Block 47.60 36.83 29.36 27.91 19.98 16.31 11.42 11.90 12.29 12.45 Gross Block 74.58 61.49 50.53 46.43 36.44 31.18 25.10 24.58 23.99 23.21 Accumulated Depreciation 26.98 24.66 21.18 18.52 16.46 14.87 13.68 12.68 11.70 10.76 Non Current Assets 50.84 38.88 30.35 29.26 21.61 17.92 11.85 12.35 12.72 13.24 Capital Work in Progress 0.00 0.23 0.00 0.00 0.34 0.65 0.00 0.00 0.06 0.43 Non Current Investment 0.47 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 2.77 1.76 0.95 1.30 1.24 0.91 0.38 0.41 0.33 0.31 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 51.43 30.94 24.11 25.01 9.56 15.94 6.77 8.80 4.24 5.83 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 29.42 20.51 13.72 11.71 7.28 12.11 4.25 5.33 1.56 1.88 Sundry Debtors 10.03 5.10 7.36 10.16 1.58 1.61 0.42 0.51 0.48 0.86 Cash & Bank 2.15 0.12 0.10 0.11 0.16 0.45 0.12 0.02 0.01 0.02 Other Current Assets 9.83 0.08 0.04 0.02 0.55 1.77 1.97 2.94 2.19 3.06 Short Term Loans & Adv. 9.16 5.13 2.89 3.01 0.54 1.72 1.93 2.56 2.15 3.02 Net Current Assets -34.67 -54.90 -9.59 -7.89 1.50 -1.55 -9.08 -7.92 -13.90 -9.94 Total Assets 102.27 69.82 54.46 54.27 31.17 33.86 18.62 21.15 16.96 19.07

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -27.75 2.83 -13.05 -1.63 -1.68 -1.62 -2.59 -7.79 1.28 0.52 PBT -22.18 -14.35 -13.87 -11.37 -0.49 3.14 -5.94 -3.49 -4.48 -5.72 Adjustment 8.03 6.61 4.31 3.53 2.51 2.96 2.07 1.75 1.83 1.49 Changes in Working Capital -13.76 10.58 -3.49 6.20 -3.58 -7.51 1.13 -6.29 3.99 4.84 Cash after chg. in Working capital -27.91 2.83 -13.05 -1.63 -1.56 -1.41 -2.75 -8.03 1.33 0.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.16 0.00 0.00 0.00 -0.12 -0.21 0.15 0.24 -0.05 -0.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -14.39 -11.32 -4.09 -9.64 -4.94 -6.72 -0.50 -0.56 -0.39 -0.90 Net Fixed Assets -12.86 -11.19 -4.10 -9.65 -4.95 -6.73 -0.52 -0.53 -0.41 -0.90 Net Investments -0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -1.11 -0.13 0.01 0.01 0.01 0.01 0.02 -0.03 0.02 0.00 Cash from Financing Activity 42.56 8.49 17.13 11.22 6.33 8.67 3.19 8.36 -0.90 0.39 Net Cash Inflow / Outflow 0.42 0.00 -0.01 -0.05 -0.29 0.33 0.10 0.01 -0.01 0.01 Opening Cash & Equivalents 0.00 0.00 0.11 0.16 0.45 0.12 0.02 0.01 0.02 0.01 Closing Cash & Equivalent 0.42 0.00 0.10 0.11 0.16 0.45 0.12 0.02 0.01 0.02

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) -11.54 -6.93 -6.18 -32.53 -24.38 -37.27 -40.14 -34.47 -31.28 -26.84 ROA -20.42% -16.57% -6.40% -27.09% -1.88% 11.16% -29.10% -17.07% -25.13% -29.92% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% ROCE -33.53% -32.89% -41.69% -50.32% 3.18% 0.00% 0.00% 0.00% 0.00% 0.00% Fixed Asset Turnover 1.66 1.95 0.82 0.75 1.79 1.85 0.55 0.84 0.55 0.36 Receivable days 24.43 20.80 80.66 69.12 9.61 7.13 12.49 8.84 19.04 52.52 Inventory Days 80.66 57.15 117.03 111.83 58.49 57.41 127.53 61.29 48.75 62.90 Payable days 140.38 99.66 254.01 229.85 78.25 109.07 199.77 144.78 221.93 344.21 Cash Conversion Cycle -35.29 -21.70 -56.32 -48.90 -10.16 -44.52 -59.76 -74.64 -154.14 -228.80 Total Debt/Equity -2.57 -2.43 -2.77 -1.47 -1.51 -1.26 -0.66 -0.64 -0.60 -0.70 Interest Cover -3.59 -5.43 -7.70 -6.65 0.47 2.76 -4.43 -3.68 -3.96 -8.57

Top Investors:

sravani reddy gantla

subba reddy bhimavarapu

sunil v. chawda

kumuda katasani

manoj s. chawda

aakanksha m chawda

snigdha vankineni

devarapally venkateswara reddy

satyanarayana reddy bandi

Annual Reports:

News Update:

Oxygenta Pharma - Quarterly Results
28th Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback